This inventor holds 1 USPTO granted patent. Top assignees: Array Biopharma Inc., Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 333 
1 out of 1,534 
Years Active: 2012
Title: Rebecca Jane Booth: Innovator in Pharmaceutical Chemistry
Introduction
Rebecca Jane Booth is a notable inventor based in Cheshire, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating hyperproliferative diseases.
Latest Patents
Rebecca holds a patent for her invention titled "Crystalline forms of 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide." This patent, which is one of her 1 patent, discloses crystalline forms of the compound that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. The patent also outlines methods for using these compounds in treatment and pharmaceutical compositions containing them.
Career Highlights
Throughout her career, Rebecca has worked with prominent companies in the pharmaceutical industry, including Array Biopharma Inc. and AstraZeneca. Her work has focused on innovative solutions to complex medical challenges, particularly in the realm of cancer treatment.
Collaborations
Rebecca has collaborated with esteemed colleagues, including Allison L. Marlow and Eli M. Wallace. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Rebecca Jane Booth is a pioneering inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. Her innovative approaches and collaborations highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile